Clinical Trial Update: Ertapenem Study in Pediatric Patients Who Have Urinary Tract Infections, Skin Infections or Community-acquired Pneumonia (0826-036) [Phase 2]

View source ↗

Summary

Phase 2 study of ertapenem in pediatric patients with urinary tract infections, pneumonia, and soft tissue infections completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia
• Soft Tissue Infection
• Urinary Tract Infection

Drugs mentioned

• Invanz (ertapenem)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Urinary Tract Infections, Bacterial Pneumonia | Phase 2 | Status: COMPLETED